Ji Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ji Zhou has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Peng Liu
Department of Orthopedic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China
5 shared publicationsZhuan Wang
Department of Orthopedic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China
3 shared publicationsGuoqiang Ding
Department of Orthopedic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China
2 shared publicationsJiabing Li
Department of Orthopedic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China
2 shared publicationsJiang Hu
Department of Orthopedic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China
2 shared publicationsKe Tan
Department of Orthopedic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China
2 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Hemiarthroplasty as management for solitary metastasis of the proximal humerus: a retrospective study
1. With the continuous advancement of medical technologies and systemic cancer therapies, the life expectancy of patients with primary malignancies has significantly improved. As a consequence, the...
- 20 August 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Open AccessHemiarthroplasty as management for solitary metastasis of the proximal humerus: a retrospective study
1. With the continuous advancement of medical technologies and systemic cancer therapies, the life expectancy of patients with primary malignancies has significantly improved. As a consequence, the...
- Open Access
- 12 June 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2517818
Evaluation of enhanced pain management programs for patients undergoing surgery for severe knee osteoarthritis: a retrospective study
Surgical intervention is a primary treatment for advanced knee osteoarthritis (OA), yet effective postoperative pain management remains suboptimal. This study aimed to evaluate the clinical outcomes of different postoperative analgesic protocols to inform optimized perioperative pain strategies. A retrospective analysis was conducted on 714 patients with knee OA who underwent total knee arthroplasty (TKA, n = 551), unicompartmental knee arthroplasty (UKA, n = 92), or high tibial osteotomy (HTO, n = 71). Patients were categorized into three groups (A, B, C) based on the postoperative analgesic regimen. Clinical parameters, including visual analogue scale (VAS) scores, knee range of motion (ROM), Hospital for Special Surgery (HSS) scores, emotional state, quadriceps strength, complication rates, and length of hospital stay, were compared. Statistical analyses were performed using factorial ANOVA. Significant differences in VAS scores at 24 h (static), 72 h (static), and 24 h (dynamic), ROM at 72 h, and HSS scores at 3 months were identified among groups, surgical procedures, and their interactions (p < 0.05). Differences in ROM at 24 h and HSS scores at 6 months were noted between groups and procedures, respectively (p < 0.05). VAS scores at 72 h (dynamic) also varied significantly by interaction effects (p < 0.05). Emotional status, quadriceps strength, and hospital stay length differed significantly between groups or procedures (p < 0.05). Complication rates were lower in Group C (22.03%) compared to Group A (46.61%) and Group B (26.45%) (p < 0.05). Optimized perioperative analgesic protocols are associated with improved pain control, enhanced functional recovery, and reduced complication rates in knee osteoarthritis surgery. Further validation through prospective, multicenter studies is recommended.
- 12 June 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2517818
Open AccessEvaluation of enhanced pain management programs for patients undergoing surgery for severe knee osteoarthritis: a retrospective study
Surgical intervention is a primary treatment for advanced knee osteoarthritis (OA), yet effective postoperative pain management remains suboptimal. This study aimed to evaluate the clinical outcomes of different postoperative analgesic protocols to inform optimized perioperative pain strategies. A retrospective analysis was conducted on 714 patients with knee OA who underwent total knee arthroplasty (TKA, n = 551), unicompartmental knee arthroplasty (UKA, n = 92), or high tibial osteotomy (HTO, n = 71). Patients were categorized into three groups (A, B, C) based on the postoperative analgesic regimen. Clinical parameters, including visual analogue scale (VAS) scores, knee range of motion (ROM), Hospital for Special Surgery (HSS) scores, emotional state, quadriceps strength, complication rates, and length of hospital stay, were compared. Statistical analyses were performed using factorial ANOVA. Significant differences in VAS scores at 24 h (static), 72 h (static), and 24 h (dynamic), ROM at 72 h, and HSS scores at 3 months were identified among groups, surgical procedures, and their interactions (p < 0.05). Differences in ROM at 24 h and HSS scores at 6 months were noted between groups and procedures, respectively (p < 0.05). VAS scores at 72 h (dynamic) also varied significantly by interaction effects (p < 0.05). Emotional status, quadriceps strength, and hospital stay length differed significantly between groups or procedures (p < 0.05). Complication rates were lower in Group C (22.03%) compared to Group A (46.61%) and Group B (26.45%) (p < 0.05). Optimized perioperative analgesic protocols are associated with improved pain control, enhanced functional recovery, and reduced complication rates in knee osteoarthritis surgery. Further validation through prospective, multicenter studies is recommended.
- 26 May 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (13) , 8631
ASO Author Reflections: Are Older Patients with Proximal Femoral Bone Metastases Fit for Endoprosthetic Replacement?
- 26 May 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (13) , 8631
ASO Author Reflections: Are Older Patients with Proximal Femoral Bone Metastases Fit for Endoprosthetic Replacement?
- 23 May 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (13) , 8623-8630
Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral Bone Metastases
Due to radical resection, endoprosthetic reconstruction (EPR) is more invasive and increases the risk of dislocation. Therefore, the suitability of EPR for
- 23 May 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (13) , 8623-8630
Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral Bone Metastases
Due to radical resection, endoprosthetic reconstruction (EPR) is more invasive and increases the risk of dislocation. Therefore, the suitability of EPR for
- Open Access
- 5 May 2021
- Published by Wiley in Orthopaedic Surgery
- Vol. 13 (4) , 1269-1276
Application of Enhanced Recovery after Surgical Treatment of the Occipitocervical Region
Objective: The concept of enhanced recovery after surgery (ERAS) has been proposed to provide guidance for the improved postoperative rehabilitation of patients with occipitocervical region disease (ORD).Methods: This study retrospectively investigated 208 consecutive patients (116 men and 92 women) ranging in age from 22 to 76 years with ORD between July 2014 and June 2017 in our medical center, who were divided into three groups that received different preoperative, intraoperative, and postoperative management plans: traditional group (n = 73), ameliorated group (n = 70), and ERAS group (n = 65). We compiled a range of data relating to demographics and postoperative changes in hemoglobin and albumin, surgery duration, intraoperative blood loss, number of postoperative hospitalization days and expenses, readmission rates, and visual analog scale pain symptoms. Data were statistically evaluated using one‐way analysis of variance with Student–Newman–Keuls‐q post hoc tests or chi‐square tests.Results: There were no significant differences in terms of age (P = 0.235), gender (P = 0.691), body mass index (P = 0.723), American Society of Anesthesiologists grade (0.747), lesion character (P = 0.337) and lesion site (P = 0.957) between the three groups. Within a 6 months follow‐up period, there was no significant difference between the three groups in terms of surgery duration (P = 0.225), blood loss (P = 0.172), changes in hemoglobin (P = 0.255) and albumin (P = 0.178). However, postoperative hospitalization days (P = 0.000), postoperative costs (P = 0.019) and improvement of pain symptoms (P = 0.000) in ERAS group were significantly lower or higher than those in traditional group or ameliorated group, respectively. There were 29 (39.73%), 22 (31.43%), and 13 (20.00%), recorded cases of postoperative complications in traditional group, ameliorated group and ERAS group, respectively; complications in ERAS group were significantly lower than those in other two groups (P = 0.043). Moreover, all of the complications were mitigated effectively by the infusion of fluid, analgesia, treatment of infections, or antiemetic medications. There were 2 (2.74%), 3 (4.29%) and 2 (3.08%), recorded cases of re‐admission in traditional group, ameliorated group and ERAS group, respectively, but there were no statistically significant differences when compared across the three groups (P = 0.866).Conclusions: ERAS can provide benefits when it applied to patients undergoing ORD surgery mainly in terms of reducing postoperative complications, however, ERAS does not increase the economic burden of patients or decrease the risk of readmission.
- 5 May 2021
- Published by Wiley in Orthopaedic Surgery
- Vol. 13 (4) , 1269-1276
Open AccessApplication of Enhanced Recovery after Surgical Treatment of the Occipitocervical Region
Objective: The concept of enhanced recovery after surgery (ERAS) has been proposed to provide guidance for the improved postoperative rehabilitation of patients with occipitocervical region disease (ORD).Methods: This study retrospectively investigated 208 consecutive patients (116 men and 92 women) ranging in age from 22 to 76 years with ORD between July 2014 and June 2017 in our medical center, who were divided into three groups that received different preoperative, intraoperative, and postoperative management plans: traditional group (n = 73), ameliorated group (n = 70), and ERAS group (n = 65). We compiled a range of data relating to demographics and postoperative changes in hemoglobin and albumin, surgery duration, intraoperative blood loss, number of postoperative hospitalization days and expenses, readmission rates, and visual analog scale pain symptoms. Data were statistically evaluated using one‐way analysis of variance with Student–Newman–Keuls‐q post hoc tests or chi‐square tests.Results: There were no significant differences in terms of age (P = 0.235), gender (P = 0.691), body mass index (P = 0.723), American Society of Anesthesiologists grade (0.747), lesion character (P = 0.337) and lesion site (P = 0.957) between the three groups. Within a 6 months follow‐up period, there was no significant difference between the three groups in terms of surgery duration (P = 0.225), blood loss (P = 0.172), changes in hemoglobin (P = 0.255) and albumin (P = 0.178). However, postoperative hospitalization days (P = 0.000), postoperative costs (P = 0.019) and improvement of pain symptoms (P = 0.000) in ERAS group were significantly lower or higher than those in traditional group or ameliorated group, respectively. There were 29 (39.73%), 22 (31.43%), and 13 (20.00%), recorded cases of postoperative complications in traditional group, ameliorated group and ERAS group, respectively; complications in ERAS group were significantly lower than those in other two groups (P = 0.043). Moreover, all of the complications were mitigated effectively by the infusion of fluid, analgesia, treatment of infections, or antiemetic medications. There were 2 (2.74%), 3 (4.29%) and 2 (3.08%), recorded cases of re‐admission in traditional group, ameliorated group and ERAS group, respectively, but there were no statistically significant differences when compared across the three groups (P = 0.866).Conclusions: ERAS can provide benefits when it applied to patients undergoing ORD surgery mainly in terms of reducing postoperative complications, however, ERAS does not increase the economic burden of patients or decrease the risk of readmission.
- 1 January 2019
- Vol. 23 (1) , 29-36
Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5
OBJECTIVE: It was the aim of this study to investigate whether miR-339 may affect osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) by targeting DLX5, thereby alleviating osteoporosis. MATERIALS AND METHODS: BMSCs were isolated from the bone marrow of mice. The expression levels of miR-339 and DLX5 during the process of osteogenesis was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Meanwhile, the expression of downstream osteogenesis-associated proteins, such as runt-related transcription factor 2 (RUNX2) and osteopontin (OPN), were also detected after overexpression or inhibition of miR-339. The alkaline phosphatase (ALP) activity was measured in cells by ALP activity assay kit. Alizarin red staining was performed to reveal the cell mineralization ability. The luciferase reporter gene assay was used to identify the targeted pairings of miR-339 and DLX5 genes. In addition, the expression of DLX5 was detected by Western blot analysis after overexpression or knockdown of miR-339. Rescue test was applied to evaluate whether miR-339 could affect the differentiation of BMSCs by inhibiting the expression of DLX5. RESULTS: ORT-PCR showed that miR-339 expression gradually decreased while the expression of DLX5 increased during the induction culture of BMSCs. After overexpression of miR-339 in BMSCs, the expression levels of ALP, RUNX2, and OPN were reduced. Besides, ALP activity assay showed a decreased cell ALP activity. RUNX2 protein expression was also decreased. In addition, Alizarin red staining detected a significant increase in cell mineralization, whereas silencing miR-339 resulted in an opposite result. These results indicated that miR-339 could regulate the osteogenic differentiation of BMSCs. Subsequently, we predicted using bioinformatics software that miR-339 might target DLX5, and validated this hypothesis by luciferase reporter assay. Finally. Western blot and ALP activity assay revealed that DLX5 could reverse the inhibitory effect of overexpression of miR-339 on osteogenic differentiation of BMSCs. CONCLUSIONS: Down-regulation of miR-339 can promote osteogenic differentiation of BMSCs by targeting DLX5, thereby relieving osteoporosis.
- 1 January 2019
- Vol. 23 (1) , 29-36
Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5
OBJECTIVE: It was the aim of this study to investigate whether miR-339 may affect osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) by targeting DLX5, thereby alleviating osteoporosis. MATERIALS AND METHODS: BMSCs were isolated from the bone marrow of mice. The expression levels of miR-339 and DLX5 during the process of osteogenesis was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Meanwhile, the expression of downstream osteogenesis-associated proteins, such as runt-related transcription factor 2 (RUNX2) and osteopontin (OPN), were also detected after overexpression or inhibition of miR-339. The alkaline phosphatase (ALP) activity was measured in cells by ALP activity assay kit. Alizarin red staining was performed to reveal the cell mineralization ability. The luciferase reporter gene assay was used to identify the targeted pairings of miR-339 and DLX5 genes. In addition, the expression of DLX5 was detected by Western blot analysis after overexpression or knockdown of miR-339. Rescue test was applied to evaluate whether miR-339 could affect the differentiation of BMSCs by inhibiting the expression of DLX5. RESULTS: ORT-PCR showed that miR-339 expression gradually decreased while the expression of DLX5 increased during the induction culture of BMSCs. After overexpression of miR-339 in BMSCs, the expression levels of ALP, RUNX2, and OPN were reduced. Besides, ALP activity assay showed a decreased cell ALP activity. RUNX2 protein expression was also decreased. In addition, Alizarin red staining detected a significant increase in cell mineralization, whereas silencing miR-339 resulted in an opposite result. These results indicated that miR-339 could regulate the osteogenic differentiation of BMSCs. Subsequently, we predicted using bioinformatics software that miR-339 might target DLX5, and validated this hypothesis by luciferase reporter assay. Finally. Western blot and ALP activity assay revealed that DLX5 could reverse the inhibitory effect of overexpression of miR-339 on osteogenic differentiation of BMSCs. CONCLUSIONS: Down-regulation of miR-339 can promote osteogenic differentiation of BMSCs by targeting DLX5, thereby relieving osteoporosis.